The Health Care and Youth Inspectorate (IGJ) recorded a slight increase in the number of incident reports with the sterilisation product Essure in 2014. It appears that there is a group of women who experience serious health problems after Essure sterilisation. The complaints reported by women are a cause of concern for us.
Research into complaints
To get an even better understanding of these complaints, we called on women with complaints to report to the Dutch National Healthcare Report Centre. The National Institute for Public Health and the Environment (RIVM) was asked to analyse the complaints. The research has now been completed, but if you have complaints or questions you can contact the National Health Care Report Centre (www.landelijkmeldpuntzorg.nl).
Sales in the Netherlands stopped
Effective 1 July 2017, Bayer will stop selling Essure in the Netherlands. In addition, Bayer informed us on the 4th of August 2017 that the CE certificate of Essure has been suspended by the notified body for 90 days, starting on the 3rd of August 2017.
Would you like to know more about Essure and our role? Read these frequently asked questions and answers about Essure and the research.